General Information of the Compound
| Compound ID |
CP0465809
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(10H-Anthracen-9-ylidene)-1-methyl-piperidine
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-(10H-Anthracen-9-ylidene)-1-methyl-piperidine
4-(10H-anthracen-9-ylidene)-1-methyl-piperidine
BDBM50097218
CHEMBL348459
SCHEMBL13921290
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H21N
|
||||||||||||||||||
| Molecular Weight |
275.395
|
||||||||||||||||||
| Canonical SMILES |
CN1CCC(CC1)=C1c2ccccc2Cc2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H21N/c1-21-12-10-15(11-13-21)20-18-8-4-2-6-16(18)14-17-7-3-5-9-19(17)20/h2-9H,10-14H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZOARGTMABFXNDY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound